These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


418 related items for PubMed ID: 2567647

  • 1. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
    De Natale G, De Natale F, Marino A.
    Clin Ter; 1989 Apr 15; 129(1):3-16. PubMed ID: 2567647
    [Abstract] [Full Text] [Related]

  • 2. Pharmacologic options for the control of peptic ulcer disease.
    Levine JB.
    Adv Intern Med; 1984 Apr 15; 30():425-47. PubMed ID: 6152108
    [No Abstract] [Full Text] [Related]

  • 3. Drug therapy of peptic ulcer disease.
    Ching CK, Lam SK.
    Br J Hosp Med; 1984 Apr 15; 54(2-3):101-6. PubMed ID: 7551483
    [Abstract] [Full Text] [Related]

  • 4. Medical treatment of peptic ulcers.
    Deveney CW, Deveney KE.
    Surg Annu; 1985 Apr 15; 17():219-33. PubMed ID: 3883541
    [Abstract] [Full Text] [Related]

  • 5. [Antisecretory therapy strategy for patients with bleeding and perforated gastroduodenal ulcers].
    Evseev MA, Ivakhov GB, Golovin RA.
    Khirurgiia (Mosk); 2009 Apr 15; (3):46-52. PubMed ID: 19391208
    [No Abstract] [Full Text] [Related]

  • 6. Current concepts in clinical therapeutics: peptic ulcer disease.
    Siepler JK, Mahakian K, Trudeau WT.
    Clin Pharm; 1986 Feb 15; 5(2):128-42. PubMed ID: 2869852
    [Abstract] [Full Text] [Related]

  • 7. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases].
    Miagkova LP, Grebenev AL, Kkhorshed AM.
    Klin Med (Mosk); 1991 Mar 15; 69(3):27-34. PubMed ID: 1676773
    [No Abstract] [Full Text] [Related]

  • 8. Famotidine: clinical applications of a new H2-receptor antagonist. May 16, 1986, Carmel, California.
    Am J Med; 1986 Oct 24; 81(4B):1-64. PubMed ID: 2877568
    [No Abstract] [Full Text] [Related]

  • 9. [Mechanism of action and therapeutic effectiveness of histamine H2 receptor blockaders in peptic ulcer].
    Glubochenko VG, Shcherbak VV.
    Vrach Delo; 1985 Feb 24; (2):13-5. PubMed ID: 2859701
    [No Abstract] [Full Text] [Related]

  • 10. [A comparative evaluation of the efficacy of sucralfate and H2-histamine blockaders in treating peptic ulcer].
    Ivashkin VT, Tkachenko EI, Grinevich VB, Sultanov VK, Inozemtsev SA.
    Ter Arkh; 1989 Feb 24; 61(8):59-62. PubMed ID: 2573963
    [Abstract] [Full Text] [Related]

  • 11. [Antacids and muscarinic and histamine H2 receptor blockaders in the treatment of peptic ulcer].
    Ivashkin VT, Minasian GA.
    Klin Med (Mosk); 1987 Jan 24; 65(1):24-31. PubMed ID: 2882061
    [No Abstract] [Full Text] [Related]

  • 12. Peptic ulceration.
    Weir DG.
    Br Med J (Clin Res Ed); 1988 Jan 16; 296(6616):195-200. PubMed ID: 2892567
    [No Abstract] [Full Text] [Related]

  • 13. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T, Lemaire M, Agostini H.
    Eur J Gastroenterol Hepatol; 1995 Jul 16; 7(7):661-5. PubMed ID: 8590162
    [Abstract] [Full Text] [Related]

  • 14. [H2 receptor antagonists and intragastric acidity].
    Dammann HG, Walter TA, Müller P, Simon B.
    Dtsch Med Wochenschr; 1984 Nov 16; 109(46):1767-9. PubMed ID: 6094136
    [No Abstract] [Full Text] [Related]

  • 15. Medical treatment of peptic ulcer disease.
    Andersen BN.
    Acta Chir Scand Suppl; 1988 Nov 16; 547():88-92. PubMed ID: 2906493
    [Abstract] [Full Text] [Related]

  • 16. [Current locally acting agents in the treatment of peptic ulcer].
    Ryss ES.
    Klin Med (Mosk); 1986 Aug 16; 64(8):18-27. PubMed ID: 2878103
    [No Abstract] [Full Text] [Related]

  • 17. [Pathophysiologic bases of the pharmacotherapy of peptic ulcer].
    Grigor'ev PIa, Isakov VA, Vasil'eva ZI.
    Klin Med (Mosk); 1988 Nov 16; 66(11):19-27. PubMed ID: 2907071
    [No Abstract] [Full Text] [Related]

  • 18. Drugs for treatment of peptic ulcers.
    Med Lett Drugs Ther; 1991 Nov 29; 33(858):111-4. PubMed ID: 1682791
    [No Abstract] [Full Text] [Related]

  • 19. [Which drug for peptic ulcer?].
    Hameeteman W, Tytgat GN.
    Ned Tijdschr Geneeskd; 1985 Aug 31; 129(35):1673-6. PubMed ID: 2864643
    [No Abstract] [Full Text] [Related]

  • 20. [Pharmacological efficacy of bismuth tripotassium dicitrate in peptic ulcer].
    Belousov IuB, Karpov OI, Belousov DIu, Beketov AS.
    Ter Arkh; 2007 Aug 31; 79(2):58-66. PubMed ID: 17460971
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.